首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1517762

細胞解離市場的胰蛋白酶-EDTA 解決方案 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、按地區和競爭的應用細分，2019-2029F

Trypsin-EDTA Solution for Cell Dissociation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application By Region and Competition, 2019-2029F

出版日期: 2024年07月21日 | 出版商:

TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年全球細胞解離胰蛋白酶-EDTA 解決方案市場估值為10.5 億美元，預計在預測期內將出現令人印象深刻的成長，到2029 年複合年成長率為6.24%。蛋白酶-EDTA 解決方案市場是一個充滿活力的市場以及生物技術和生命科學產業的關鍵部分。胰蛋白酶-EDTA溶液是一種廣泛使用的試劑，在細胞培養和細胞生物學研究中發揮關鍵作用。此解決方案主要用作細胞解離劑，使研究人員能夠將貼壁細胞從培養表面分離，用於各種應用，包括細胞傳代、傳代培養和細胞收穫。

市場概況
預測期	2025-2029
2023 年市場規模	10.5億美元
2029 年市場規模	14.9億美元
2024-2029 年複合年成長率	6.24%
成長最快的細分市場	細胞培養
最大的市場	北美洲

推動全球細胞解離胰蛋白酶-EDTA解決方案市場成長的關鍵因素包括再生醫學、藥物開發和癌症生物學等領域基於細胞的研究範圍的擴大。研究人員依靠胰蛋白酶-EDTA 解決方案來維持健康且可行的細胞培養物，使其成為全球實驗室不可或缺的工具。此外，細胞療法的日益普及以及生產臨床級細胞對高品質解離試劑的需求正在提振市場需求。

該市場的特點是存在眾多供應商和製造商，提供一系列量身定做的胰蛋白酶-EDTA 解決方案，以滿足研究人員的特定需求。這些解決方案具有各種配方、濃度和包裝尺寸，可滿足不同的應用和實驗室規模。此外，由於對細胞治療和生物製造的日益重視，產品配方的創新，例如無動物源和重組胰蛋白酶替代品，正在獲得關注。

主要市場促進因素

擴大細胞研究範圍

基於細胞的療法正在興起

生物製藥製造

主要市場挑戰

監管和品質控制挑戰

道德和監管問題

主要市場趨勢

對細胞研究的需求不斷增加

全球生物技術中心的發展

細分市場洞察

應用洞察

區域洞察

Global Trypsin-EDTA Solution for Cell Dissociation Market was valued at USD 1.05 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.24% through 2029. The Global Trypsin-EDTA Solution for Cell Dissociation Market is a dynamic and crucial segment within the biotechnology and life sciences industry. Trypsin-EDTA solution is a widely used reagent that plays a pivotal role in cell culture and cell biology research. This solution primarily serves as a cell dissociation agent, enabling researchers to detach adherent cells from culture surfaces for various applications, including cell passage, subculturing, and cell harvesting.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 1.05 Billion
Market Size 2029	USD 1.49 Billion
CAGR 2024-2029	6.24%
Fastest Growing Segment	Cell Culture
Largest Market	North America

Key factors driving the growth of the Global Trypsin-EDTA Solution for Cell Dissociation Market include the expanding scope of cell-based research in areas such as regenerative medicine, drug development, and cancer biology. Researchers rely on trypsin-EDTA solutions to maintain healthy and viable cell cultures, making it an indispensable tool in laboratories worldwide. Additionally, the growing adoption of cell-based therapies and the need for high-quality dissociation reagents to produce clinical-grade cells are bolstering market demand.

The market is characterized by the presence of numerous suppliers and manufacturers offering a range of trypsin-EDTA solutions tailored to meet the specific needs of researchers. These solutions come in various formulations, concentrations, and packaging sizes, catering to diverse applications and laboratory sizes. Furthermore, innovations in product formulations, such as animal origin-free and recombinant trypsin alternatives, are gaining traction due to the rising emphasis on cell therapy and biomanufacturing.

Key Market Drivers

Expanding Scope of Cell-Based Research

The expanding scope of cell-based research is a prominent driving force behind the burgeoning Global Trypsin-EDTA Solution for Cell Dissociation Market. Cell-based research has become the cornerstone of numerous scientific disciplines, ranging from regenerative medicine and cancer biology to drug discovery and developmental biology. As researchers delve deeper into the intricacies of cellular processes, they rely heavily on trypsin-EDTA solutions to facilitate the detachment of adherent cells from culture surfaces. This pivotal step is essential for cell passage, subculturing, and cell harvesting, making trypsin-EDTA a fundamental reagent in laboratories worldwide.

One of the key factors fueling the market's growth is the remarkable versatility of cell-based research. Scientists harness the power of cell cultures to study disease mechanisms, screen potential drug candidates, and develop advanced therapies, including stem cell-based treatments and immunotherapies. These innovative applications demand a constant supply of high-quality cells, intensifying the requirement for reliable dissociation reagents like trypsin-EDTA.

Moreover, the expansion of cell-based research extends beyond the boundaries of traditional laboratory settings. Collaborative efforts among academia, pharmaceutical companies, and biotechnology firms have ushered in an era of interdisciplinary research, where cell biology intersects with fields like genomics, proteomics, and bioinformatics. This interdisciplinary approach amplifies the demand for cell culture reagents, further propelling the market's growth trajectory.

As the global scientific community continues to uncover the intricate mechanisms governing cellular behavior, the need for advanced tools and reagents remains paramount. This includes not only the development of novel cell culture techniques but also the refinement of existing protocols to meet the demands of cutting-edge research. In this context, trypsin-EDTA solutions stand as a foundational element, ensuring the reliable isolation of cells for downstream experiments.

Cell-Based Therapies on the Rise

The surge in cell-based therapies is a significant catalyst propelling the growth of the Global Trypsin-EDTA Solution for Cell Dissociation Market. Cell-based therapies have emerged as a groundbreaking approach to treating a wide spectrum of diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. These therapies harness the potential of living cells, making precise cell culture and expansion processes imperative. Among the crucial tools required for this purpose, trypsin-EDTA solutions play a pivotal role in detaching adherent cells from culture surfaces, allowing researchers and manufacturers to produce clinically viable cell populations.

The development and success of cell-based therapies are highly dependent on the quality and consistency of the cell populations used. This necessitates the use of reliable and well-characterized dissociation reagents like trypsin-EDTA, which ensure that cells maintain their viability, functionality, and genetic stability throughout the culture and expansion phases. As the demand for cell-based therapies continues to rise, so does the need for high-quality cell dissociation solutions.

Stem cell therapies, in particular, have gained prominence within the field of regenerative medicine. These therapies hold tremendous promise for regenerating damaged tissues and organs, offering hope to patients with conditions previously considered incurable. The production of clinical-grade stem cells for these treatments requires meticulous cell culture techniques, making trypsin-EDTA solutions an essential component in the production process.

Immunotherapies, another category of cell-based treatments, have also witnessed exponential growth. These therapies harness the power of a patient's immune cells to target and eradicate cancer cells or other disease-causing agents. The reliable isolation and expansion of immune cells are critical in the manufacturing of personalized immunotherapies, driving up the demand for dissociation reagents like trypsin-EDTA.

Furthermore, the regulatory landscape for cell-based therapies is evolving, with increasing scrutiny on manufacturing processes and product quality. This heightened regulatory oversight underscores the importance of using well-established and validated reagents such as trypsin-EDTA, which can aid in meeting stringent quality and safety standards.

Biopharmaceutical Manufacturing

The booming field of biopharmaceutical manufacturing is a compelling factor propelling the growth of the Global Trypsin-EDTA Solution for Cell Dissociation Market. Biopharmaceuticals, which include therapeutic proteins, monoclonal antibodies, and vaccines produced using living cells, have transformed the landscape of modern medicine. In this complex and highly regulated industry, trypsin-EDTA solutions have emerged as indispensable tools at various stages of the manufacturing process.

One of the primary applications of trypsin-EDTA in biopharmaceutical manufacturing is in cell line development. Scientists working to produce biopharmaceuticals often need to generate stable and high-yielding cell lines. Trypsin-EDTA solutions are crucial for the routine subculturing and maintenance of these cells, ensuring their continued viability and productivity.

Large-scale fermentation, another critical step in biopharmaceutical manufacturing, involves the growth of cells to produce the desired therapeutic proteins or antibodies. To achieve optimal cell density and productivity, it is essential to efficiently harvest these cells from the bioreactor. Trypsin-EDTA solutions play a crucial role in this process by effectively detaching the adherent cells from the culture surfaces, facilitating their downstream processing.

Moreover, the biopharmaceutical industry places a strong emphasis on product quality, safety, and regulatory compliance. Manufacturing processes must adhere to rigorous standards to ensure consistent and safe therapeutic products. Using well-established and validated reagents such as trypsin-EDTA is essential in meeting these stringent quality and safety requirements. Biopharmaceutical manufacturing is a global endeavor, with production facilities distributed across different regions to cater to a global patient population. This geographic dispersion of manufacturing sites contributes to the sustained demand for trypsin-EDTA solutions on a global scale.

Furthermore, the biopharmaceutical sector is characterized by continuous innovation and a growing pipeline of novel therapies. As biotechnology companies and research institutions develop new biologics and vaccines, they rely on trusted and versatile reagents like trypsin-EDTA to maintain the integrity and viability of their cell cultures throughout the research and development process.

Key Market Challenges

Regulatory and Quality Control Challenges

The Trypsin-EDTA Solution for Cell Dissociation Market, an essential player in the world of biotechnology, faces mounting regulatory and quality control challenges that can constrain its momentum. The imperative to ensure that products meet strict regulatory standards is now more pronounced than ever, given the critical role these solutions play in supporting groundbreaking research and therapeutic innovations.

Regulatory compliance is a cornerstone in this domain, especially when the end applications include biopharmaceutical manufacturing or clinical applications. Global regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have set stringent benchmarks for product quality and safety. For manufacturers, navigating these multifaceted regulatory landscapes is not only time-consuming but also resource intensive. Complying with one set of guidelines may not guarantee acceptance in another region, thereby complicating global market expansions.

Equally challenging is the issue of consistent product quality. Researchers and manufacturers rely on trypsin-EDTA solutions for their cell culture endeavors, requiring these reagents to exhibit consistent performance. Any variability in quality can lead to unpredictable cell culture outcomes, jeopardizing entire research projects or manufacturing batches. This necessitates manufacturers to implement rigorous quality control measures, thereby increasing production costs.

Furthermore, as the market expands, there's a heightened emphasis on traceability and transparency. Stakeholders are demanding detailed information about the origins of the ingredients, especially with concerns about animal-derived components, such as traditional trypsin. The push towards ethical sourcing further compounds regulatory challenges.

Ethical and Regulatory Concerns

The Global Trypsin-EDTA Solution for Cell Dissociation Market is facing a growing set of ethical and regulatory concerns that have the potential to significantly impact its growth and operations. These concerns primarily revolve around the ethical use of animal-derived trypsin, potential contamination risks, and the need for ethical alternatives in the market.

One of the central ethical concerns involves the traditional sourcing of trypsin from animal pancreases, such as pigs and cows. The extraction of trypsin from these sources raises questions about animal welfare and ethical treatment. Animal-derived trypsin production can also introduce variability into the product due to differences in animal sources, potentially affecting the reliability of research and biopharmaceutical manufacturing. These ethical concerns have prompted a shift towards the development and adoption of animal origin-free and recombinant trypsin alternatives.

Regulatory bodies worldwide are increasingly focused on ensuring the ethical and safe use of trypsin-EDTA solutions in research and therapeutic applications. These regulations aim to mitigate contamination risks associated with animal-derived trypsin, such as the transmission of pathogens and prions. Manufacturers must adhere to stringent quality control measures to demonstrate the safety and efficacy of their products, adding complexity to the production process.

Key Market Trends

Increasing Demand for Cell-Based Research

The Global Trypsin-EDTA Solution for Cell Dissociation Market is experiencing a significant upswing, primarily propelled by the surging demand for cell-based research. Cell-based research has become the cornerstone of scientific exploration across diverse fields, including regenerative medicine, drug discovery, and molecular biology. As researchers delve deeper into the intricacies of cellular functions, the need for precise and reliable cell dissociation reagents like trypsin-EDTA solutions has never been greater.

Cell-based research offers a versatile platform for studying diseases, testing potential drug candidates, and unraveling fundamental biological processes. In this context, trypsin-EDTA solutions play a pivotal role by facilitating the detachment of adherent cells from culture surfaces, enabling researchers to manipulate and analyze cells efficiently. This critical step is integral to various applications, such as cell passage, subculturing, and cell harvesting.

The expanding scope of cell-based research has resulted in an ever-increasing demand for trypsin-EDTA solutions, making them a staple in laboratories worldwide. Whether it's investigating cancer mechanisms, developing regenerative therapies, or conducting basic cellular studies, trypsin-EDTA remains an indispensable tool, ensuring that cells are maintained in optimal conditions for experimentation.

Moreover, the significance of cell-based research extends beyond academia, with the pharmaceutical and biotechnology industries heavily reliant on it for drug development and biomanufacturing. As the biopharmaceutical sector continues to grow, so does the need for high-quality cell dissociation reagents to ensure the consistency and reliability of cell culture processes.

Growth of Global Biotechnology Hubs

The growth of global biotechnology hubs is playing a pivotal role in boosting the Global Trypsin-EDTA Solution for Cell Dissociation Market. These biotechnology clusters, concentrated in regions like North America, Europe, and the Asia-Pacific, have become epicenters of cutting-edge research, innovation, and collaboration in the life sciences. This dynamic environment is driving the demand for cell culture reagents, including trypsin-EDTA solutions, as researchers and biopharmaceutical companies rely heavily on these reagents for their work.

In North America, biotechnology hubs like the Boston-Cambridge area and the San Francisco Bay Area are home to a multitude of biotech startups, established companies, and world-renowned research institutions. These hubs foster collaboration between academia and industry, creating a robust demand for cell culture tools. Researchers in these regions require high-quality trypsin-EDTA solutions to maintain cell cultures consistently and reliably as they push the boundaries of scientific discovery.

Europe boasts biotechnology clusters in regions such as Cambridge (UK), Basel (Switzerland), and the BioValley in France and Germany. These hubs are characterized by a thriving life sciences ecosystem, attracting talent and investment. The presence of numerous biotech companies and research organizations drives the need for advanced cell culture reagents like trypsin-EDTA solutions.

In recent years, the Asia-Pacific region has emerged as a significant player in the biotechnology landscape, with biotech hubs developing in cities like Shanghai, Singapore, and Hyderabad. These hubs are experiencing rapid growth, driven by increasing healthcare expenditure, a growing patient population, and significant investments in research and development. As biotech firms and research institutions in Asia-Pacific intensify their efforts, the demand for cell culture reagents, including trypsin-EDTA solutions, is on the rise.

The proximity of research institutions, biopharmaceutical companies, and academic centers in these biotechnology hubs creates a synergistic effect, driving the demand for trypsin-EDTA solutions. Researchers in these regions rely on these reagents to maintain healthy and viable cell cultures, whether they are working on drug discovery, biomanufacturing, or cell-based therapies.

Segmental Insights

Application Insights

Based on the Application, the Cell Culture segment emerged as the dominant in the global market for Global Trypsin-EDTA Solution for Cell Dissociation Market in 2023. Cell culture is a foundational technique in various scientific and industrial fields, including biopharmaceuticals, regenerative medicine, cancer research, drug discovery, and developmental biology. Researchers across these domains rely on cell cultures to study diseases, screen drug candidates, and conduct fundamental research. As a result, cell culture is a ubiquitous application with diverse and extensive use cases.

Regional Insights

North America emerged as the dominant in the global Trypsin-EDTA Solution for Cell Dissociation Market in 2023, holding the largest market share. North America, particularly the United States, is home to a well-developed and advanced biotechnology and pharmaceutical industry. The region hosts numerous biotech companies, pharmaceutical giants, and research institutions that heavily rely on cell culture techniques for drug discovery, biomanufacturing, and biomedical research. This extensive industry presence drives a substantial demand for trypsin-EDTA solutions. North America consistently ranks among the regions with the highest research and development (R&D) spending.

Key Market Players

Thermo Fisher Scientific Inc (Gibco)

Lonza Group Ltd

Merck KGa

Sartorius AG

Biosera Europe

Fujifilm (Irvine Scientific)

Chargen Life Sciences LLP

ScienCell Research Laboratories, Inc.

STEMCELL Technologies Canada Inc.

PromoCell GmbH

Report Scope:

In this report, the Global Trypsin-EDTA Solution for Cell Dissociation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Trypsin-EDTA Solution for Cell Dissociation Market, By Type:

0.25% Solution 0.05% Solution

Trypsin-EDTA Solution for Cell Dissociation Market, By Application:

Insulin Manufacturing Vaccines Manufacturing Cell Culture Other

Trypsin-EDTA Solution for Cell Dissociation Market, By Region:

United States
Canada
Mexico

France
United Kingdom
Italy
Germany
Spain

China
India
Japan
Australia
South Korea

Brazil
Argentina
Colombia

South Africa
Saudi Arabia
UAE
Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Trypsin-EDTA Solution for Cell Dissociation Market.

Available Customizations:

Global Trypsin-EDTA Solution for Cell Dissociation Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Global Trypsin-EDTA Solution for Cell Dissociation Market Outlook

4.1. Market Size & Forecast
- 4.1.1. By Value
4.2. Market Share & Forecast
- 4.2.1. By Type (0.25% Solution, 0.05% Solution)
- 4.2.2. By Application (Insulin Manufacturing, Vaccines Manufacturing, Cell Culture, Other)
- 4.2.3. By Company (2023)
4.3. Market Map
- 4.3.1. By Type
- 4.3.2. By Application
- 4.3.3. By Region

5. Asia Pacific Trypsin-EDTA Solution for Cell Dissociation Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type
- 5.2.2. By Application
- 5.2.3. By Country
5.3. Asia Pacific: Country Analysis
- 5.3.1. China Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 5.3.1.1. Market Size & Forecast
    - 5.3.1.1.1. By Value
  - 5.3.1.2. Market Share & Forecast
    - 5.3.1.2.1. By Type
    - 5.3.1.2.2. By Application
- 5.3.2. India Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 5.3.2.1. Market Size & Forecast
    - 5.3.2.1.1. By Value
  - 5.3.2.2. Market Share & Forecast
    - 5.3.2.2.1. By Type
    - 5.3.2.2.2. By Application
- 5.3.3. Australia Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 5.3.3.1. Market Size & Forecast
    - 5.3.3.1.1. By Value
  - 5.3.3.2. Market Share & Forecast
    - 5.3.3.2.1. By Type
    - 5.3.3.2.2. By Application
- 5.3.4. Japan Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 5.3.4.1. Market Size & Forecast
    - 5.3.4.1.1. By Value
  - 5.3.4.2. Market Share & Forecast
    - 5.3.4.2.1. By Type
    - 5.3.4.2.2. By Application
- 5.3.5. South Korea Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 5.3.5.1. Market Size & Forecast
    - 5.3.5.1.1. By Value
  - 5.3.5.2. Market Share & Forecast
    - 5.3.5.2.1. By Type
    - 5.3.5.2.2. By Application

6. Europe Trypsin-EDTA Solution for Cell Dissociation Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Application
- 6.2.3. By Country
6.3. Europe: Country Analysis
- 6.3.1. France Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Application
- 6.3.2. Germany Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Application
- 6.3.3. Spain Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Application
- 6.3.4. Italy Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 6.3.4.1. Market Size & Forecast
    - 6.3.4.1.1. By Value
  - 6.3.4.2. Market Share & Forecast
    - 6.3.4.2.1. By Type
    - 6.3.4.2.2. By Application
- 6.3.5. United Kingdom Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 6.3.5.1. Market Size & Forecast
    - 6.3.5.1.1. By Value
  - 6.3.5.2. Market Share & Forecast
    - 6.3.5.2.1. By Type
    - 6.3.5.2.2. By Application

7. North America Trypsin-EDTA Solution for Cell Dissociation Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Application
- 7.2.3. By Country
7.3. North America: Country Analysis
- 7.3.1. United States Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Application
- 7.3.2. Mexico Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Application
- 7.3.3. Canada Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Application

8. South America Trypsin-EDTA Solution for Cell Dissociation Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Application
- 8.2.3. By Country
8.3. South America: Country Analysis
- 8.3.1. Brazil Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Application
- 8.3.2. Argentina Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Application
- 8.3.3. Colombia Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Application

9. Middle East and Africa Trypsin-EDTA Solution for Cell Dissociation Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Application
- 9.2.3. By Country
9.3. MEA: Country Analysis
- 9.3.1. South Africa Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Application
- 9.3.2. Saudi Arabia Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Application
- 9.3.3. UAE Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Application
- 9.3.4. Egypt Trypsin-EDTA Solution for Cell Dissociation Market Outlook
  - 9.3.4.1. Market Size & Forecast
    - 9.3.4.1.1. By Value
  - 9.3.4.2. Market Share & Forecast
    - 9.3.4.2.1. By Type
    - 9.3.4.2.2. By Application

10. Market Dynamics

10.1. Drivers
10.2. Challenges

11. Market Trends & Developments

11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions

12. Global Trypsin-EDTA Solution for Cell Dissociation Market: SWOT Analysis

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product

14. Competitive Landscape

14.1. Thermo Fisher Scientific Inc (Gibco)
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (In case of listed)
- 14.1.5. Recent Developments
- 14.1.6. SWOT Analysis
14.2. Lonza Group Ltd
14.3. Merck KGa
14.4. Sartorius AG
14.5. Biosera Europe
14.6. Fujifilm (Irvine Scientific)
14.7. Chargen Life Sciences LLP
14.8. ScienCell Research Laboratories, Inc
14.9. STEMCELL Technologies Canada Inc.
14.10.PromoCell GmbH

15. Strategic Recommendations

16. About Us & Disclaimer

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

胰蛋白酶市場 - 全球產業規模、佔有率、趨勢、機會和預測，按來源、應用、最終用戶、地區、競爭細分，2019-2029F

胰蛋白酶市場規模、佔有率、趨勢分析報告：按原料、按應用、按最終用途、按地區、細分市場預測，2024-2030

FAQ

細胞解離市場的胰蛋白酶-EDTA 解決方案 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、按地區和競爭的應用細分，2019-2029F

Trypsin-EDTA Solution for Cell Dissociation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application By Region and Competition, 2019-2029F

主要市場促進因素

主要市場挑戰

主要市場趨勢

細分市場洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：全球細胞解離胰蛋白酶-EDTA 解決方案市場前景

第 5 章：亞太地區細胞解離胰蛋白酶-EDTA 解決方案市場展望

第 6 章：歐洲細胞分離胰蛋白酶-EDTA 解決方案市場前景

第 7 章：北美細胞解離胰蛋白酶-EDTA 解決方案市場前景

第 8 章：南美洲細胞解離胰蛋白酶-EDTA 解決方案市場前景

第 9 章：中東和非洲細胞解離胰蛋白酶-EDTA 解決方案市場前景

第 10 章：市場動態

第 11 章：市場趨勢與發展

第 12 章：細胞分離市場的全球胰蛋白酶-EDTA 解決方案：SWOT 分析

第 13 章：波特的五力分析

第14章：競爭格局

第 15 章：策略建議

第16章調查會社について,免責事項

Key Market Players

Report Scope:

Trypsin-EDTA Solution for Cell Dissociation Market, By Type:

Trypsin-EDTA Solution for Cell Dissociation Market, By Application:

Trypsin-EDTA Solution for Cell Dissociation Market, By Region:

Competitive Landscape

Available Customizations:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global Trypsin-EDTA Solution for Cell Dissociation Market Outlook

5. Asia Pacific Trypsin-EDTA Solution for Cell Dissociation Market Outlook

6. Europe Trypsin-EDTA Solution for Cell Dissociation Market Outlook

7. North America Trypsin-EDTA Solution for Cell Dissociation Market Outlook

8. South America Trypsin-EDTA Solution for Cell Dissociation Market Outlook

9. Middle East and Africa Trypsin-EDTA Solution for Cell Dissociation Market Outlook

10. Market Dynamics

11. Market Trends & Developments

12. Global Trypsin-EDTA Solution for Cell Dissociation Market: SWOT Analysis

13. Porter's Five Forces Analysis

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer